Overview Fundamentals API Earnings EOD API Sample Code Pricing

Chugai Pharmaceutical Co. Ltd (CHGCF PINK) stock market data APIs

$35.25 0(0%) as of July 18, 2024
Price chart is built with Anychart

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.

Chugai Pharmaceutical Co. Ltd Financial Data Overview

54 337 M
1 645 M
1 036 076 M
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CHGCF',
Type: 'Common Stock',
Name: 'Chugai Pharmaceutical Co. Ltd',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000C0DPL2',
CIK: '1453934',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
HomeCategory: NULL,
IsDelisted: false,

Chugai Pharmaceutical Co. Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 036 076 M
  • EBITDA 472 391 M
  • Earnings Per Share 1.25
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Chugai Pharmaceutical Co. Ltd Earnings via APIs

  • Latest Release 2024-04-24
  • EPS/Forecast 42.91

Get Chugai Pharmaceutical Co. Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?